داروسازی فارابی
دفارا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 19,980 2.99
Close Price: 19,930
Financial Ratios
AGM
Interim
2026/07/21 Fiscal Year 2026/03/2012 Month | 2026/06/17 Fiscal Year 2025/03/1912 Month | 2025/05/27 Fiscal Year 2025/03/2012 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 39.22 | - | 32.28 | |
Gross Profit to Sales | 42.81 | - | 34.67 | |
Operating Margin | 33.43 | - | 19.97 | |
Gross Profit to Sales | 36.7 | - | 25.85 | |
Net Profit to Gross Profit | 106.88 | - | 124.87 | |
Return on Assets (ROA) | 30.16 | - | 21.44 | |
Return on Capital (%) | 172.97 | - | 573.09 | |
Return on Equity (ROE) | 61.76 | - | 49.67 | |
Working Capital Return | 81.08 | - | 76.12 | |
Fixed Asset Return | 287.62 | - | 167.15 | |
Loan Benefit Assessment | 2.05 | - | 2.32 | |
Current Ratio | 1.75 | 1.51 | 1.51 | |
Quick Ratio | 1.43 | 1.3 | 1.3 | |
Liquidity Ratio | 0.04 | 0.02 | 0.02 | |
Net Working Capital | 19,638,622 | 12,046,104 | 12,046,104 | |
Current Assets Ratio | 0.87 | 0.84 | 0.84 | |
Inventory Turnover | 94.9 | - | 86.49 | |
Receivables Collection Period | 315.24 | - | 356.41 | |
Inventory to Working Capital | 0.43 | 0.41 | 0.41 | |
Working Capital Turnover | 2.07 | - | 2.36 | |
Fixed Asset Turnover | 7.33 | - | 5.18 | |
Total Asset Turnover | 0.77 | - | 0.66 | |
Debt Ratio | 0.51 | 0.57 | 0.57 | |
Debt to Equity | 1.05 | 1.32 | 1.32 | |
Long-Term Debt to Equity | 0.04 | 0.03 | 0.03 | |
Current Debt to Equity | 1.01 | 1.28 | 1.28 | |
Equity Ratio | 48.84 | 43.16 | 43.16 | |
Debt Coverage Ratio | 6.02 | 8.92 | 8.92 |